MRNS logo

Marinus Pharmaceuticals (MRNS) Operating Profit

Annual Operating Profit

-$131.49 M
-$18.70 M-16.58%

December 31, 2023


Summary


Performance

MRNS Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMRNSprofitabilitymetrics:

Quarterly Operating Profit

-$21.08 M
+$9.21 M+30.40%

September 30, 2024


Summary


Performance

MRNS Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMRNSprofitabilitymetrics:

TTM Operating Profit

-$122.62 M
+$10.57 M+7.93%

September 30, 2024


Summary


Performance

MRNS TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMRNSprofitabilitymetrics:

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

MRNS Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-16.6%0.0%0.0%
3 y3 years-93.5%+27.8%-8.7%
5 y5 years-253.7%+27.8%-8.7%

MRNS Operating Profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-35.6%at low-26.1%+42.7%-41.8%+8.7%
5 y5-year-141.6%at low-36.3%+42.7%-125.3%+8.7%
alltimeall time-9117.3%at low-2173.5%+42.7%<-9999.0%+8.7%

Marinus Pharmaceuticals Operating Profit History

DateAnnualQuarterlyTTM
Sep 2024
-
-$21.08 M(-30.4%)
-$122.62 M(-7.9%)
Jun 2024
-
-$30.29 M(-15.5%)
-$133.19 M(-0.9%)
Mar 2024
-
-$35.82 M(+1.1%)
-$134.34 M(+2.2%)
Dec 2023
-$131.49 M(+16.6%)
-$35.44 M(+12.0%)
-$131.49 M(+5.0%)
Sep 2023
-
-$31.65 M(+0.7%)
-$125.26 M(+1.3%)
Jun 2023
-
-$31.44 M(-4.6%)
-$123.71 M(-4.1%)
Mar 2023
-
-$32.96 M(+12.8%)
-$129.04 M(+14.4%)
Dec 2022
-$112.79 M(+16.4%)
-$29.21 M(-2.9%)
-$112.79 M(+1.9%)
Sep 2022
-
-$30.10 M(-18.1%)
-$110.69 M(+11.0%)
Jun 2022
-
-$36.77 M(+120.0%)
-$99.76 M(+15.4%)
Mar 2022
-
-$16.71 M(-38.4%)
-$86.48 M(-10.8%)
Dec 2021
-$96.93 M(+42.7%)
-$27.12 M(+41.5%)
-$96.93 M(+11.0%)
Sep 2021
-
-$19.17 M(-18.4%)
-$87.32 M(+4.1%)
Jun 2021
-
-$23.48 M(-13.5%)
-$83.85 M(+10.0%)
Mar 2021
-
-$27.16 M(+55.2%)
-$76.25 M(+12.2%)
Dec 2020
-$67.94 M(+24.8%)
-$17.50 M(+11.5%)
-$67.94 M(+3.1%)
Sep 2020
-
-$15.70 M(-1.2%)
-$65.91 M(+2.8%)
Jun 2020
-
-$15.88 M(-15.8%)
-$64.11 M(+5.5%)
Mar 2020
-
-$18.85 M(+21.9%)
-$60.74 M(+11.6%)
Dec 2019
-$54.42 M(+46.4%)
-$15.47 M(+11.3%)
-$54.42 M(+10.6%)
Sep 2019
-
-$13.90 M(+11.1%)
-$49.22 M(+5.8%)
Jun 2019
-
-$12.51 M(-0.2%)
-$46.55 M(+6.7%)
Mar 2019
-
-$12.54 M(+22.1%)
-$43.60 M(+17.3%)
Dec 2018
-$37.18 M
-$10.27 M(-8.4%)
-$37.18 M(+16.8%)
DateAnnualQuarterlyTTM
Sep 2018
-
-$11.22 M(+17.3%)
-$31.84 M(+28.2%)
Jun 2018
-
-$9.57 M(+56.5%)
-$24.83 M(+25.6%)
Mar 2018
-
-$6.11 M(+23.8%)
-$19.77 M(+3.8%)
Dec 2017
-$19.04 M(-32.6%)
-$4.94 M(+17.2%)
-$19.04 M(-5.0%)
Sep 2017
-
-$4.21 M(-6.5%)
-$20.04 M(-9.7%)
Jun 2017
-
-$4.51 M(-16.3%)
-$22.19 M(-16.3%)
Mar 2017
-
-$5.38 M(-9.2%)
-$26.53 M(-6.1%)
Dec 2016
-$28.24 M(+15.6%)
-$5.93 M(-6.9%)
-$28.24 M(-5.3%)
Sep 2016
-
-$6.37 M(-28.0%)
-$29.81 M(+5.4%)
Jun 2016
-
-$8.84 M(+24.6%)
-$28.29 M(+14.9%)
Mar 2016
-
-$7.10 M(-5.4%)
-$24.62 M(+0.7%)
Dec 2015
-$24.43 M(+105.0%)
-$7.50 M(+54.7%)
-$24.44 M(+19.3%)
Sep 2015
-
-$4.85 M(-6.2%)
-$20.49 M(+13.3%)
Jun 2015
-
-$5.17 M(-25.2%)
-$18.08 M(+11.8%)
Mar 2015
-
-$6.92 M(+94.5%)
-$16.17 M(+35.7%)
Dec 2014
-$11.92 M(+121.6%)
-$3.56 M(+45.9%)
-$11.92 M(+21.0%)
Sep 2014
-
-$2.44 M(-25.3%)
-$9.85 M(+12.8%)
Jun 2014
-
-$3.26 M(+22.4%)
-$8.74 M(+22.8%)
Mar 2014
-
-$2.67 M(+79.0%)
-$7.12 M(+32.3%)
Dec 2013
-$5.38 M(+277.1%)
-$1.49 M(+12.6%)
-$5.38 M(+38.3%)
Sep 2013
-
-$1.32 M(-19.4%)
-$3.89 M(+51.5%)
Jun 2013
-
-$1.64 M(+77.0%)
-$2.57 M(+177.0%)
Mar 2013
-
-$927.20 K
-$927.20 K
Dec 2012
-$1.43 M
-
-

FAQ

  • What is Marinus Pharmaceuticals annual operating income?
  • What is the all time high annual operating profit for Marinus Pharmaceuticals?
  • What is Marinus Pharmaceuticals annual operating profit year-on-year change?
  • What is Marinus Pharmaceuticals quarterly operating income?
  • What is the all time high quarterly operating profit for Marinus Pharmaceuticals?
  • What is Marinus Pharmaceuticals quarterly operating profit year-on-year change?
  • What is Marinus Pharmaceuticals TTM operating income?
  • What is the all time high TTM operating profit for Marinus Pharmaceuticals?
  • What is Marinus Pharmaceuticals TTM operating profit year-on-year change?

What is Marinus Pharmaceuticals annual operating income?

The current annual operating profit of MRNS is -$131.49 M

What is the all time high annual operating profit for Marinus Pharmaceuticals?

Marinus Pharmaceuticals all-time high annual operating income is -$1.43 M

What is Marinus Pharmaceuticals annual operating profit year-on-year change?

Over the past year, MRNS annual operating income has changed by -$18.70 M (-16.58%)

What is Marinus Pharmaceuticals quarterly operating income?

The current quarterly operating profit of MRNS is -$21.08 M

What is the all time high quarterly operating profit for Marinus Pharmaceuticals?

Marinus Pharmaceuticals all-time high quarterly operating income is -$927.20 K

What is Marinus Pharmaceuticals quarterly operating profit year-on-year change?

Over the past year, MRNS quarterly operating income has changed by $0.00 (0.00%)

What is Marinus Pharmaceuticals TTM operating income?

The current TTM operating profit of MRNS is -$122.62 M

What is the all time high TTM operating profit for Marinus Pharmaceuticals?

Marinus Pharmaceuticals all-time high TTM operating income is -$927.20 K

What is Marinus Pharmaceuticals TTM operating profit year-on-year change?

Over the past year, MRNS TTM operating income has changed by $0.00 (0.00%)